The current and future impact of human papillomavirus on treatment of squamous cell carcinoma of the head and neck
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The current and future impact of human papillomavirus on treatment of squamous cell carcinoma of the head and neck
Authors
Keywords
-
Journal
ANNALS OF ONCOLOGY
Volume 25, Issue 11, Pages 2101-2115
Publisher
Oxford University Press (OUP)
Online
2014-07-24
DOI
10.1093/annonc/mdu265
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment-related outcome of oropharyngeal cancer patients differentiated by HPV dictated risk profile: a tertiary cancer centre series analysis
- (2014) P. Bossi et al. ANNALS OF ONCOLOGY
- Impact of tumor HPV status on outcome in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EXTREME trial
- (2014) J. B. Vermorken et al. ANNALS OF ONCOLOGY
- Molecular profile of head and neck squamous cell carcinomas bearing p16 high phenotype
- (2013) T. Rampias et al. ANNALS OF ONCOLOGY
- Human papillomavirus detection and comorbidity: critical issues in selection of patients with oropharyngeal cancer for treatment De-escalation trials
- (2013) M. M. Rietbergen et al. ANNALS OF ONCOLOGY
- Differential outcome of concurrent radiotherapy plus epidermal growth factor receptor inhibitors versus radiotherapy plus cisplatin in patients with human papillomavirus-related head and neck cancer
- (2013) Bella Pajares et al. BMC CANCER
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- New treatment strategies for HPV-positive head and neck cancer
- (2013) B. Kofler et al. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
- Controversies in Treatment Deintensification of Human Papillomavirus–Associated Oropharyngeal Carcinomas: Should We, How Should We, and for Whom?
- (2013) Harry Quon et al. JOURNAL OF CLINICAL ONCOLOGY
- Deintensification Candidate Subgroups in Human Papillomavirus–Related Oropharyngeal Cancer According to Minimal Risk of Distant Metastasis
- (2013) Brian O'Sullivan et al. JOURNAL OF CLINICAL ONCOLOGY
- Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial
- (2013) Jan B Vermorken et al. LANCET ONCOLOGY
- Molecular mechanisms of HPV induced carcinogenesis in head and neck
- (2013) Theodoros Rampias et al. ORAL ONCOLOGY
- The role of human papillomavirus in nongenital cancers
- (2012) Dan P. Zandberg et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Randomised Phase II study of oral lapatinib combined with chemoradiotherapy in patients with advanced squamous cell carcinoma of the head and neck: Rationale for future randomised trials in human papilloma virus-negative disease
- (2012) Kevin Harrington et al. EUROPEAN JOURNAL OF CANCER
- Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer-systematic review and meta-analysis of trends by time and region
- (2012) Hisham Mehanna et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Tobacco Smoking and Increased Risk of Death and Progression for Patients With p16-Positive and p16-Negative Oropharyngeal Cancer
- (2012) Maura L. Gillison et al. JOURNAL OF CLINICAL ONCOLOGY
- Natural course of distant metastases following radiotherapy or chemoradiotherapy in HPV-related oropharyngeal cancer
- (2012) Shao Hui Huang et al. ORAL ONCOLOGY
- Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial
- (2011) M. R. Posner et al. ANNALS OF ONCOLOGY
- Phase 2 trial of oxaliplatin and pemetrexed as an induction regimen in locally advanced head and neck cancer
- (2011) Jill Gilbert et al. CANCER
- Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
- (2011) Anil K. Chaturvedi et al. JOURNAL OF CLINICAL ONCOLOGY
- Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2010) V. Gregoire et al. ANNALS OF ONCOLOGY
- Impact of HPV infection on the clinical outcome of p-CAIR trial in head and neck cancer
- (2010) Miroslaw Snietura et al. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
- Induction Docetaxel, Cisplatin, and Cetuximab Followed by Concurrent Radiotherapy, Cisplatin, and Cetuximab and Maintenance Cetuximab in Patients With Locally Advanced Head and Neck Cancer
- (2010) Athanassios Argiris et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Significance of p16INK4Aand Human Papillomavirus in Patients With Oropharyngeal Cancer Treated on TROG 02.02 Phase III Trial
- (2010) Danny Rischin et al. JOURNAL OF CLINICAL ONCOLOGY
- Tirapazamine, Cisplatin, and Radiation Versus Cisplatin and Radiation for Advanced Squamous Cell Carcinoma of the Head and Neck (TROG 02.02, HeadSTART): A Phase III Trial of the Trans-Tasman Radiation Oncology Group
- (2010) Danny Rischin et al. JOURNAL OF CLINICAL ONCOLOGY
- Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
- (2010) K. Kian Ang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Squamous cell carcinoma of the oropharynx in Australian males induced by human papillomavirus vaccine targets
- (2010) Angela M. Hong et al. VACCINE
- Interaction between Tobacco and Alcohol Use and the Risk of Head and Neck Cancer: Pooled Analysis in the International Head and Neck Cancer Epidemiology Consortium
- (2009) M. Hashibe et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Effect of HPV-Associated p16INK4A Expression on Response to Radiotherapy and Survival in Squamous Cell Carcinoma of the Head and Neck
- (2009) Pernille Lassen et al. JOURNAL OF CLINICAL ONCOLOGY
- Induction Chemotherapy and Cetuximab for Locally Advanced Squamous Cell Carcinoma of the Head and Neck: Results From a Phase II Prospective Trial
- (2009) Merrill S. Kies et al. JOURNAL OF CLINICAL ONCOLOGY
- E6 and E7 Gene Silencing and Transformed Phenotype of Human Papillomavirus 16-Positive Oropharyngeal Cancer Cells
- (2009) T. Rampias et al. JNCI-Journal of the National Cancer Institute
- Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
- (2009) James A Bonner et al. LANCET ONCOLOGY
- Moderate predictive value of demographic and behavioral characteristics for a diagnosis of HPV16-positive and HPV16-negative head and neck cancer
- (2009) Gypsyamber D’Souza et al. ORAL ONCOLOGY
- HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer
- (2009) Pernille Lassen et al. RADIOTHERAPY AND ONCOLOGY
- Molecular Pathology of Head and Neck Cancer: Implications for Diagnosis, Prognosis, and Treatment
- (2008) Sara I. Pai et al. Annual Review of Pathology-Mechanisms of Disease
- Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas
- (2008) Harriët C. Hafkamp et al. INTERNATIONAL JOURNAL OF CANCER
- Improved Survival of Patients With Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical Trial
- (2008) C. Fakhry et al. JNCI-Journal of the National Cancer Institute
- Distinct Risk Factor Profiles for Human Papillomavirus Type 16–Positive and Human Papillomavirus Type 16–Negative Head and Neck Cancers
- (2008) Maura L. Gillison et al. JNCI-Journal of the National Cancer Institute
- Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
- (2008) Jan B. Vermorken et al. NEW ENGLAND JOURNAL OF MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started